Segmentectomy vs lobectomy for small middle-lung lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial compares two types of lung surgery for certain small lung cancers in the middle part of the lung: removing a segment (segmentectomy) versus removing a whole lobe (lobectomy). It aims to see which surgery works better while balancing cancer control and lung function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 75 years old
- Your lung tumor is 6 to 20 mm (about 0.6 to 2 cm) wide
- The tumor is located in the middle third of the lung—not the right middle lobe
- Your scans show it has not spread to lymph nodes in the center of the chest or to distant places
- You are healthy enough for surgery, with acceptable breathing test results (FEV1 at least 1 liter and at least 70%)
- Your surgery plan should be able to remove all visible cancer with clear margins (R0) for either option
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two lung-surgery options for small lung adenocarcinoma (≤ 2 cm): removing a lung segment versus removing an entire lobe. It aims to see which operation controls the cancer while preserving lung function.
This trial compares two types of lung surgery—removing a small lung segment versus removing an entire lung lobe—for small lung adenocarcinoma (≤ 2 cm). It may help you choose the safest approach that still controls the cancer.
This study compares two lung cancer surgeries: segmentectomy (removing only the part of the lung with the tumor) and lobectomy (removing the entire lobe). It is for people with early-stage non-small cell lung cancer that is 2–3 cm and more solid than hazy on a CT scan. The goal is to see which surgery works better while preserving lung function.
This study compares two types of surgery for small, early-stage lung cancers that are deep inside the lung. It aims to see if removing only a small part of the lung (segmentectomy) works as well as removing a whole lobe (lobectomy), which may help patients recover faster and preserve more lung function.
This trial compares two types of surgery for early-stage lung cancer tumors that are 2-3 cm in size: removing just the affected segment of the lung (segmentectomy) or removing the entire lobe (lobectomy). It aims to see if the smaller surgery works just as well and may help you recover faster.
This trial compares two types of lung surgery for early-stage non-small cell lung cancer. You may qualify if you have a small tumor (2 cm or less) with specific features on a CT scan. The goal is to see which surgery offers better outcomes.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.